USPTO serial 79348056
Serial No. 79348056
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 7, 2023
- Examiner
- HERRERA-MARCUS, ROSELLE MORALDE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 79348056?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
JANET G RICCIUTI
JANET G RICCIUTI JANET GILBERT RICCIUTI PC2003 KALORAMA ROAD NWWASHINGTON, DC 20009UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical compounds for use in the manufacture of pharmaceutical products and vaccines, especially calcium phosphates and calcium hydroxyapatite | ACTIVE | — |
| 005 | Pharmaceutical preparations used in the treatment of cancers and immune diseases in humans and animals; vaccines for medical and veterinary use; preparation of vaccines for medical and veterinary use in kit form | ACTIVE | — |
| 010 | Medical vaccine preparation instruments presented in the form of kits composed of disposable analytical instruments, namely, syringes and needles for medical use, scalpels, forceps for medical use, droppers for medical use, containers for medical samples especially tubes, chromatography columns | ACTIVE | — |
| 040 | Manufacture of pharmaceutical products especially therapeutic vaccines to order for others; manufacture of personalized therapeutic vaccines from biological samples | ACTIVE | — |
| 042 | Research and development with respect to vaccines and chemical preparations for vaccine manufacture; genotyping; design of personalized therapeutic vaccines from biological samples; scientific research and providing scientific information and analysis related to design of personalized therapeutic vaccines from biological samples; scientific research and providing scientific information and analysis related to genotyping | ACTIVE | — |
| 044 | Healthcare services; Medical diagnosis of cancers and immune diseases; Medical screening of cancers and immune diseases; Professional information and advice with respect to health, especially with respect to vaccination | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HASTIM
- Other trademarks owned by HASTIM
- Other trademarks owned by HASTIM
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 4, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 9, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 9, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 7, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 7, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 7, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 22, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 22, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 21, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 2, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 2, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 2, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 14, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 11, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 11, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 11, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 7, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 17, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 17, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 6, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 5, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 31, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 30, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 26, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 25, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |